Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q3 EPS of ($0.68), $0.09 better than the analyst estimate of ($0.77). Revenue for the quarter came in at $4.3 million versus the consensus estimate of $3.11 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.